Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
TWD 13.6
(-14.73%)
TWD 13.6
(-14.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 137.99 Million TWD | 4.36% |
| 2022 | 132.23 Million TWD | 36.95% |
| 2021 | 96.56 Million TWD | 157.52% |
| 2020 | 37.49 Million TWD | -76.87% |
| 2019 | 162.11 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 112 Million TWD | -18.84% |
| 2024 Q2 | 140.57 Million TWD | 32.41% |
| 2023 FY | 137.99 Million TWD | 4.36% |
| 2023 Q2 | 169.45 Million TWD | 7.16% |
| 2023 Q1 | 158.13 Million TWD | 19.58% |
| 2023 Q3 | 121.27 Million TWD | -28.44% |
| 2023 Q4 | 137.99 Million TWD | 13.79% |
| 2022 Q3 | 116.49 Million TWD | 0.0% |
| 2022 Q4 | 132.23 Million TWD | 13.51% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 279.112% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 152.237% |
| Level Biotechnology Inc. | -453.9 Million TWD | 130.402% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 214.452% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 170.263% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 72.393% |
| GlycoNex Incorporation | -148.56 Million TWD | 192.884% |
| VBI | -25.31 Million TWD | 645.09% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | -242.708% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 152.553% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -351.289% |
| Visgeneer Inc. | 31.28 Million TWD | -341.104% |
| Mycenax Biotech Inc. | 207 Million TWD | 33.339% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 120.275% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 202.788% |
| Neith Corporation | -150.31 Million TWD | 191.806% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 77.798% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 339.334% |
| Enimmune corporation | -314.15 Million TWD | 143.925% |
| TaiRx, Inc. | -147.86 Million TWD | 193.322% |
| CHO Pharma, Inc. | -203.79 Million TWD | 167.714% |
| EirGenix Inc. | -4.58 Billion TWD | 103.008% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 262.801% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | -14.167% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 104.288% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 143.474% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 796.487% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | -333.824% |
| Lukas Biomedical Inc. | 50.75 Million TWD | -171.885% |
| RBC Bioscience Corporation | 422.18 Million TWD | 67.314% |
| BiOptic Inc. | 12.59 Million TWD | -995.894% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 114.612% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 235.974% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 183.544% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 56.174% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 314.541% |
| NaviFUS Corp. | -123.12 Million TWD | 212.074% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | -86.351% |
| Sinew Pharma Inc. | -160.34 Million TWD | 186.061% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 157.048% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 140.903% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 133.442% |
| AP Biosciences Inc | -196.52 Million TWD | 170.216% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 79.964% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 1306.566% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 116.632% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 89.833% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 133.262% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 165.92% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 195.921% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 141.748% |
| TCI GENE Inc. | -689.25 Million TWD | 120.021% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 216.023% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 110.54% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -573.705% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 235.462% |
| PharmaEngine, Inc. | -860.8 Million TWD | 116.031% |
| Savior Lifetec Corporation | -812.54 Million TWD | 116.983% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 146.003% |
| OBI Pharma, Inc. | -398.22 Million TWD | 134.653% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 137.763% |
| Acepodia, Inc. | -6.02 Billion TWD | 102.292% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 104.057% |